Clinical Trial Update: VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating VEGF Trap (aflibercept) in patients with recurrent, locally advanced, or metastatic urothelial cancers has completed and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urethral Cancer
• Urothelial Carcinoma
• Urothelial Carcinoma of the Bladder
• Urothelial Carcinoma of the Renal Pelvis and Ureter

Drugs mentioned

• VEGF Trap (aflibercept) (aflibercept)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Bladder, Distal Urethral Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-10-03